61
Joinn Laboratories(China)Co.,Ltd.
6127.HK · HKSE
$21.56 +1.70% (+$0.36)
1M -20.48%
Market Cap ¥25.6B
P/E Ratio 26.03x
Div. Yield 0.63%
ROE 11.56%
Bulios Fair Price
$11.18
48.1% downside
Current Price
$21.56
Undervalued Fair Value Overvalued
According to Bulios Fair Price, 6127.HK is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
25 /100
Expensive P/E 26.03x
EV/EBITDA 55.07x
P/S 15.12x
Growth
3 /100
Declining EPS growth 41.52%
Rev. growth 9.92%
FCF growth 24.39%
Profitability
85 /100
Strong Gross margin 20.13%
Net margin 58.08%
Op. margin 24.43%
Quality
38 /100
Average ROIC 4.11%
ROE 11.56%
ROA 9.07%
Debt
100 /100
Low Debt/Equity 0.01x
Current ratio 4.05x
Int. coverage 328.38x
Stability
65 /100
Moderate Beta 0.80x
Rev. volatility 12.35%
EPS volatility 220.75%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about 6127.HK
Online
Sector
Healthcare
Industry
Medical - Diagnostics & Research
CEO
Daniel Gao
Employees
2,649
Headquarters
Beijing
Upcoming events
04 NOV
Earnings
Upcoming earnings report